|
|
- * Multiple studies support the use of noninvasive positive pressure ventilation (NPPV) in acute exacerbations of COPD, acute cardiogenic pulmonary edema, and immunocompromised patients (organ transplant) with hypoxic respiratory failure.
* The timing of NPPV initiation is important. NPPV should be started as soon as possible, as delays increase the likelihood of intubation
* The best predictor of success is a favorable response to NPPV within the first 1 to 2 hours
o reduction in respiratory rate
o improvement in pH
o improved oxygenation
o reduction in PaCO2
* Also crucial to NPPV success is a well fitting interface (mask)
* Although patients report greater comfort with nasal masks, they also permit more air leakage through the mouth and have been associated with a higher rate of initial intolerance in the acute setting.
* For acute applications of NPPV in the ED, a full face mask is preferred
References
Garpestad E, Brennan J, Hill NS. Noninvasive ventilation for critical care. Chest 2007;132:711-20.
|